Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria
about
Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal diseaseCombined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationElevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Peripheral vascular dysfunction in chronic kidney diseaseThree-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients.Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseAssociation between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging BiomarkersEvaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay populationAssociation of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy.Can treating persistent inflammation limit protein energy wasting?Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.C-reactive protein variability is associated with vascular access outcome in hemodialysis patients.Neutrophil-dependent pentraxin-3 and reactive oxygen species production modulate endothelial dysfunction in haemodialysis patients.Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients.The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension.Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration.Study on Association of Pentraxin 3 and Diabetic Nephropathy in a Rat Model.Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey
P2860
Q24320230-1F993660-B2F8-4397-A88E-FE169A74690AQ33944773-49E9C9BC-0D16-456B-BA45-40FD7EBB1A9AQ34713240-FDB77EC0-9FD7-494F-8462-141CBCAB3D7BQ34751855-E1F6E693-363F-4AD5-AE69-05F6718A5897Q35012914-69F9EC8B-56FE-4973-A8BB-1A746312D07EQ35227705-8B5CB610-911C-4338-81E1-FEB91D6FDD0CQ35664554-85D544CE-ED2F-442A-9085-47C171F7AFFEQ36533057-D782566F-B594-4080-926B-AD0BC0E99FDCQ36551416-410AFFC1-51E7-42D5-97F8-FDD035EBF2EAQ37136183-B46CA421-E31C-46E8-8C33-356AB1BB3A1AQ37370584-9C6274B4-51C9-4E09-9C4C-773789D1D56FQ37621173-B178099F-9D63-4FEB-9BD6-5C3FE695B591Q38050186-E17A9C3E-68A0-403C-AF28-321ECC069966Q38380295-370B7EF1-A114-41AA-A004-A220AADE4051Q38618242-0EED5D46-A029-4D61-AD50-223F9087C662Q38758897-07E885E4-29C1-4511-942A-0AE2792E0BC4Q38816561-6D74FB18-3AE7-41D7-A5E3-EBE9C5E5E637Q46450702-D4445EE0-3F14-4625-A2E6-F086620F7A16Q47216784-C2436050-0DC3-4D50-92C1-FAE3152E7304Q47848978-AC8B771C-AEDC-4C41-BE02-A2CCDCC7BC74Q51129819-A91FE82D-D023-4C6A-A878-4CD9230E4E1AQ52761490-6AAA4A2A-B30D-411E-B442-EC2CE5484A79Q55223194-232E9A58-8DC0-4BD1-86A0-E8333702E79FQ55447799-6A9B9A0D-2E7A-4AE1-A6C8-3D4441DD5E0BQ57417409-F9455265-9B18-4474-A084-2834215A5432
P2860
Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of renin angiotensin sy ...... etic patients with proteinuria
@en
Effect of renin angiotensin sy ...... tic patients with proteinuria.
@nl
type
label
Effect of renin angiotensin sy ...... etic patients with proteinuria
@en
Effect of renin angiotensin sy ...... tic patients with proteinuria.
@nl
prefLabel
Effect of renin angiotensin sy ...... etic patients with proteinuria
@en
Effect of renin angiotensin sy ...... tic patients with proteinuria.
@nl
P2093
P2860
P356
P1476
Effect of renin angiotensin sy ...... etic patients with proteinuria
@en
P2093
Abdulgaffar Vural
Alper Kirkpantur
Alper Sonmez
Jonas Axelsson
Juan Jesus Carrero
Kayser Caglar
Mahmut Ilker Yilmaz
Mujdat Yenicesu
Mutlu Saglam
Tayfun Eyileten
P2860
P304
P356
10.2215/CJN.04330808
P577
2009-02-11T00:00:00Z